Company / CapEx per Share
Terns Pharmaceuticals, Inc. CapEx per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $2.05
FY2020-FY2024
Trend
-27.6%
vs FY2023
Sector context
#176 of 191
Health Care
What the data says
Among 191 Health Care companies, Terns Pharmaceuticals, Inc. is in the bottom 8% for capex per share. CapEx per Share has declined for 4 consecutive years, from $2.05 in FY2020 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of -67.2%.
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -67.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 191This company $0.00 Sector average $4.05
▼
-100.0% below sector average
Key checks
Key Insights
- Terns Pharmaceuticals, Inc.'s capex per share has declined for 4 consecutive years.
- In FY2024, capex per share decreased 27.6% year-over-year.
- Ranks #176 out of 191 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -27.6% |
| FY2023 | $0.00 | -90.4% |
| FY2022 | $0.01 | -49.0% |
| FY2021 | $0.01 | -99.3% |
| FY2020 | $2.05 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026